Literature DB >> 27091401

Serum levels of SOD and risk of autism spectrum disorder: A case-control study.

Lixuan Wang1, Jianpu Jia1, Junling Zhang1, Kuo Li2.   

Abstract

BACKGROUND: Autism is a severe developmental disorder with poorly understood etiology. This study examined the clinical significance of serum superoxide dismutase (SOD) level, a marker of oxidative stress, in children with autism spectrum disorder (ASD) and typically-developing children between the ages of 2 and 6 years.
METHODS: Ninety-six children diagnosed with ASD and 96 sex and age matched typically-developing children were assessed for serum levels of SOD at admission. S0D were assayed by colorimetry, and severity of ASD was evaluated with the Childhood Autism Rating Scale (CARS) Score. The influence of serum SOD levels on ASD was performed by conditional logistic regression analysis, which allows adjustment for confounding factors.
RESULTS: The median serum SOD levels were significantly (P<0.001) lower in children with ASD as compared to typically-developing children [146 (IQR: 133-165) U/ml and 180 (168-199) U/ml, respectively]. Levels of SOD increased with decreasing severity of ASD as defined by the CARS score (r=-0.432, P<0.0001). After adjusting for all other possible covariates, SOD remained can be seen as an independent indictor of ASD with an adjusted odds ratio (OR) of 0.955 (95% confidence interval [CI], 0.942-0.969; P<0.001). Based on the receiver operating characteristic (ROC) curve, the optimal cutoff value of serum level of SOD as an indicator for auxiliary diagnosis of ASD was projected to be 160U/ml, which yielded a sensitivity of 84.7% and a specificity of 71.4%, with the area under the curve at 0.811 (95%CI, 0.747-0.874).
CONCLUSIONS: Our data suggests that the decreased serum SOD levels could be implicated in the pathophysiology and progression of autism in Chinese children and can be used as an independent risk indicator of ASD.
Copyright © 2016 ISDN. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Autism spectrum disorders; Oxidative stress; Risk; Superoxide dismutase

Mesh:

Substances:

Year:  2016        PMID: 27091401     DOI: 10.1016/j.ijdevneu.2016.04.004

Source DB:  PubMed          Journal:  Int J Dev Neurosci        ISSN: 0736-5748            Impact factor:   2.457


  7 in total

1.  Decreased total antioxidant capacity has a larger effect size than increased oxidant levels in urine in individuals with autism spectrum disorder.

Authors:  Kunio Yui; Nasoyuki Tanuma; Hiroshi Yamada; Yohei Kawasaki
Journal:  Environ Sci Pollut Res Int       Date:  2017-03-01       Impact factor: 4.223

Review 2.  Towards a Multivariate Biomarker-Based Diagnosis of Autism Spectrum Disorder: Review and Discussion of Recent Advancements.

Authors:  Troy Vargason; Genevieve Grivas; Kathryn L Hollowood-Jones; Juergen Hahn
Journal:  Semin Pediatr Neurol       Date:  2020-03-05       Impact factor: 1.636

Review 3.  Impaired Redox Control in Autism Spectrum Disorders: Could It Be the X in GxE?

Authors:  Vanja Mandic-Maravic; Marija Pljesa-Ercegovac; Marija Mitkovic-Voncina; Ana Savic-Radojevic; Dusica Lecic-Tosevski; Tatjana Simic; Milica Pejovic-Milovancevic
Journal:  Curr Psychiatry Rep       Date:  2017-08       Impact factor: 5.285

4.  High KEAP1, NRF2 and Low HO-1 Serum Levels in Children with Autism.

Authors:  Hamza Ayaydin; İsmail Akaltun; İsmail Koyuncu; Hakim Çelİk; Adnan Kİrmİt; Hatice Takatak
Journal:  Noro Psikiyatr Ars       Date:  2020-09-21       Impact factor: 1.339

5.  Fourier Transform Infrared Spectroscopy Based Complementary Diagnosis Tool for Autism Spectrum Disorder in Children and Adolescents.

Authors:  Gulce Ogruc Ildiz; Sevgi Bayari; Ahmet Karadag; Ersin Kaygisiz; Rui Fausto
Journal:  Molecules       Date:  2020-04-29       Impact factor: 4.411

Review 6.  Oxidative Stress in Autism Spectrum Disorder-Current Progress of Mechanisms and Biomarkers.

Authors:  Xukun Liu; Jing Lin; Huajie Zhang; Naseer Ullah Khan; Jun Zhang; Xiaoxiao Tang; Xueshan Cao; Liming Shen
Journal:  Front Psychiatry       Date:  2022-03-01       Impact factor: 4.157

7.  Serum levels of superoxide dismutases in patients with benign paroxysmal positional vertigo.

Authors:  Jing Li; Rui Wu; Bin Xia; Xinhua Wang; Mengzhou Xue
Journal:  Biosci Rep       Date:  2020-05-29       Impact factor: 3.840

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.